Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 11Adenocarcinoma, Follicular 5Thyroid Cancer, Papillary 4Xerostomia 2Thyroid Diseases 1Sialadenitis 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Infertility 1Hyperthyroidism 1Head and Neck Neoplasms 1

Interventions

temsirolimus 1selpercatinib 1pralsetinib 1cabozantinib 1acetaminophen, codeine drug combination 1Vitamin B 12 1Tramadol 1Thyrotropin-Releasing Hormone 1Thyroidectomy 1Thyroid (USP) 1Sorafenib 1Pemetrexed 1Panobinostat 1Observation 1Negative-Pressure Wound Therapy 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Metformin 1Lysine Acetyltransferase 5 1Iodine-131 1Folic Acid 1Fluorescein 1Data Collection 1Congresses as Topic 1Cisplatin 1Cetuximab 1Capsules 1Blood Cell Count 1Biopsy, Needle 1Acetaminophen 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thyroid Diseases × Iodine-131 × Clear all
NCT00673010 2025-10-09

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
20 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡